Paula Manchon-Walsh

Dr. Paula Manchon-Walsh

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
PMPaula Manchon-Walsh
Paula Manchon-Walsh
JBJosep M. Borras
Josep M. Borras
JEJ.A. Espinas
J.A. Espinas
LAL. Aliste
L. Aliste

1 December 2016 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
PMPaula Manchon-Walsh
Paula Manchon-Walsh
LAL. Aliste
L. Aliste
JEJ.A. Espinàs
J.A. Espinàs
JPJ. Prades
J. Prades
AGA. Guarga
A. Guarga
ETE.M. Targarona
E.M. Targarona

26 December 2018 in Colorectal Disease
Verified
Journal Article
Open access
PDF file
PMPaula Manchon-Walsh
Paula Manchon-Walsh
LALuisa Aliste
Luisa Aliste
SBSebastiano Biondo
Sebastiano Biondo
EBEloy Espin Basany
Eloy Espin Basany
MPMiguel Pera
Miguel Pera
JBJosep M. Borras
Josep M. Borras
Aim: The oncological risk/benefit trade‐off for laparoscopy in rectal cancer is controversial. Our aim was to compare laparoscopic vs open surgery for resection of rectal cancer, using unselected data from the public healthcare system of Catalonia (Spain).Methods: This was a multicentre retrospective cohort study of all patients who had surgery with curative intent for primary rectal cancer at Catalonian public hospitals from 2011 to 2012. We obtained follow‐up data for up to 5 years. To minimize the differences between the two groups, we performed propensity score matching on baseline patient characteristics. We used multivariate Cox proportional hazards regression analyses to assess locoregional relapse at 2 years and death at 2 and 5 years.Results: Of 1513 patients with Stage I–III rectal cancer, 933 (61.7%) had laparoscopy (conversion rate 13.2%). After applying our propensity score matching strategy (2:1), 842 laparoscopy patients were matched to 517 open surgery patients. Multivariate Cox analysis of death at 2 years [hazard ratio (HR) 0.65, 95% CI 0.48, 0.87; P = 0.004] and 5 years (HR 0.61, 95% CI 0.5, 0.75; P < 0.001) and of local relapse at 2 years (HR 0.44, 95% CI 0.27, 0.72; P = 0.001) showed laparoscopy to be an independent protective factor compared with open surgery.Conclusions: Laparoscopy results in lower locoregional relapse and long‐term mortality in rectal cancer in unselected patients with all‐risk groups included. Studies using long‐term follow‐up of cohorts and unselected data can provide information on clinically relevant outcomes to supplement randomized controlled trials.

15 May 2018 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
RVR. Vernet
R. Vernet
JBJosep M. Borras
Josep M. Borras
LAL. Aliste
L. Aliste
MAM. Antonio
M. Antonio
AGA. Guarga
A. Guarga
PMPaula Manchon-Walsh
Paula Manchon-Walsh

1 May 2011 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
PMPaula Manchon-Walsh
Paula Manchon-Walsh
JBJosep M. Borras
Josep M. Borras
JEJosep Alfons Espinas
Josep Alfons Espinas
LALuisa Aliste
Luisa Aliste

27 March 2010 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
CGColorectal Cancer OncoGuia Group
Colorectal Cancer OncoGuia Group
PMPaula Manchon-Walsh
Paula Manchon-Walsh
JBJosep M. Borras
Josep M. Borras
TFTàrsila Ferro
Tàrsila Ferro
JEJosep Alfons Espinàs
Josep Alfons Espinàs